Thrombomodulin: a multifunctional receptor modulating the endothelial quiescence.
Hemant Giri1, Indranil Biswas1, Alireza R Rezaie2
1Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Journal of Thrombosis and Haemostasis : JTH
|January 24, 2024
Summary
Thrombomodulin (TM) cytoplasmic domain signaling regulates endothelial cell quiescence by modulating PTEN pathways. This research uncovers TM
Area of Science:
- Endothelial cell biology
- Receptor signaling
- Molecular mechanisms of thrombosis
Background:
- Thrombomodulin (TM) is a cell surface receptor primarily known for its anticoagulant cofactor role.
- TM regulates multiple pathways including fibrinolysis, complement, and inflammation.
- The function of TM's extracellular domains is well-established, but its intracellular domain remains poorly understood.
Purpose of the Study:
- To investigate the physiological function of the cytoplasmic domain of Thrombomodulin (TM).
- To elucidate the role of TM intracellular signaling in endothelial cell quiescence.
- To explore the mechanism by which TM modulates Phosphatase and Tensin homolog (PTEN) signaling.
Main Methods:
- Review of existing literature on TM structure and function.
- Analysis of recent laboratory data on TM cytoplasmic domain signaling.
- Focus on TM's modulation of PTEN signaling pathways in endothelial cells.
Main Results:
- Recent data suggest TM intracellular signaling is crucial for maintaining endothelial cell quiescence.
- The TM cytoplasmic domain modulates Phosphatase and Tensin homolog (PTEN) signaling.
- This modulation appears to be a key mechanism in maintaining cellular quiescence.
Conclusions:
- The cytoplasmic domain of Thrombomodulin plays a significant, previously underappreciated role in endothelial cell function.
- TM intracellular signaling, particularly through PTEN modulation, is vital for maintaining vascular quiescence.
- Further research into TM's intracellular functions is warranted to understand its full physiological importance.
More Related Videos
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
698
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
698
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Clot Retraction and Fibrinolysis
6.0K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.0K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K


